XLO Xilio Therapeutics
- 1.090
- -0.030-2.68%
- 1.080
- -0.010-0.92%
Xilio Therapeutics News
Xilio Therapeutics | 10-Q: Quarterly report
Xilio Therapeutics' Q1 Cash And Cash Equivalents Of $34M, $30M Upfront Payment Received In April 2024 Under Gilead Agreement And Approximately $14.6M In Gross Proceeds From Private Placement In April 2024 Are Expected To Provide Cash Runway Into Q2 2025
Xilio Therapeutics' Q1 Cash And Cash Equivalents Of $34M, $30M Upfront Payment Received In April 2024 Under Gilead Agreement And Approximately $14.6M In Gross Proceeds From Private Placement In April
Xilio Therapeutics Q1 2024 GAAP EPS $(0.62) Compared To $(0.83) A Year Ago
Xilio Therapeutics Q1 2024 GAAP EPS $(0.62) Compared To $(0.83) A Year Ago
Xilio Therapeutics Cash and Cash Equivalents Were $34M as of March 31 >XLO
Xilio Therapeutics Cash and Cash Equivalents Were $34M as of March 31 >XLO
Xilio Therapeutics 1Q Loss $17.2M >XLO
Xilio Therapeutics 1Q Loss $17.2M >XLO
Xilio Therapeutics Anticipates Cash Runway Into the 2Q of 2025 >XLO
Xilio Therapeutics Anticipates Cash Runway Into the 2Q of 2025 >XLO
Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results Expect to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combina
Xilio Therapeutics Currently May Offer And Sell Shares Of Co's Common Stock Having An Aggregate Offering Price Of Up To $18.7M
Xilio Therapeutics Currently May Offer And Sell Shares Of Co's Common Stock Having An Aggregate Offering Price Of Up To $18.7M
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $
Xilio Therapeutics 13G/Amended Filing Shows Rock Springs Capital Management LP Reported A 8.71% Stake In The Co As Of March 27, 2024
Xilio Therapeutics 13G/Amended Filing Shows Rock Springs Capital Management LP Reported A 8.71% Stake In The Co As Of March 27, 2024
Xilio Therapeutics Says Repayment In Q1 2024 Of Outstanding Loan Balance Under Xilio's Loan And Security Agreement With Pacific Western Bank, Will Be Sufficient To Fund Its Operating Expenses And Capital Expenditure Requirements Into Q2 2025.
Xilio Therapeutics Says Repayment In Q1 2024 Of Outstanding Loan Balance Under Xilio's Loan And Security Agreement With Pacific Western Bank, Will Be Sufficient To Fund Its Operating Expenses And Capi
Xilio Therapeutics Q4 2023 EPS $(0.64) Up From $(0.82) YoY
Xilio Therapeutics Q4 2023 EPS $(0.64) Up From $(0.82) YoY
Xilio Therapeutics 4Q Loss/Shr 64c >XLO
Xilio Therapeutics 4Q Loss/Shr 64c >XLO
Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results On track with plans to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enha
Top Midday Gainers
CXApp (CXAI) said Monday it signed partnership and development agreements with Alphabet's (GOOG, GOOGL) Google Cloud as part of the planned launch of its software-as-a-service platform. Shares catapul
Precision Biosciences, Mesoblast, Pulse Biosciences Among Healthcare Movers
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersGalera Therapeutics (NASDAQ:GRTX) shares moved upwards by 62.8% to $0.23 during Monday's pre-market session. The market value of their outstanding shares is at $12.3 million. As per the news, t
Xilio Therapeutics, Inc. (XLO) Surges With Positive Updates
When it comes to biotech stocks, Xilio Therapeutics, Inc. (NASDAQ: XLO) emerged as a standout performer on Thursday, witnessing an astounding surge of 69% during regular trading hours. The excitement didn't stop there, as the bullish momentum carried over into the after-market session, driving an additional 20.4% increase in XLO's stock price. With eyes eagerly ...
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. The market value of their outstanding shares is at $37.1 million. Sunshine Biopharma (NASDAQ:SB
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday's pre-market session. The market value of their outstanding shares is at $14.8 million. Xilio Therapeutics (NASDAQ:XLO
Analysis
Price Target
No Data
